Abstract

PHP108 Early Access Programmes (EAPs): Review of Non- European System

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
PRM268 - EVALUATION OF REAL-WORLD DATA COLLECTION AND EVIDENCE GENERATION FROM EARLY ACCESS PROGRAM
D Stein ... M Soni
Value in Health | VOL. 21
D Stein, et. al.D Stein ... M Soni
01 Oct 2018
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case
Alice Tarantola ... Francesco Costa
Journal of Pharmaceutical Policy and Practice | VOL. 16
Alice Tarantola, et. al.Alice Tarantola ... Francesco Costa
17 May 2023
Early Access Programs; A Useful Tool to Improve Access for Patients and Manufacturers
A Gilbane ... D Dabor-Alloh
Value in Health | VOL. 20
A Gilbane, et. al.A Gilbane ... D Dabor-Alloh
01 Oct 2017
PNS245 SNAPSHOT OF EARLY ACCESS PROGRAMMES IN PORTUGAL: A NEW ACCESS HURDLE?
M Amorim ... J Felix
Value in Health | VOL. 22
M Amorim, et. al.M Amorim ... J Felix
01 Nov 2019
View more papers

More From: Value in Health

Paper Title
Journal
Date
Author
Assessing the health and welfare benefits of interventions using the Wider Societal Impacts framework
Shainur Premji ... Susan Griffin
Value in Health | VOL. -
Shainur Premji, et. al.Shainur Premji ... Susan Griffin
01 Aug 2024
First-Line Treatment with Atezolizumab plus Bevacizumab and Chemotherapy for US Patients with Metastatic, Persistent, or Recurrent Cervical Cancer: A Cost-Effectiveness Analysis
Jianying Lei ... Na Li
Value in Health | VOL. -
Jianying Lei, et. al.Jianying Lei ... Na Li
01 Aug 2024
Editorial Board
-
Value in Health | VOL. 27
--
01 Aug 2024
How Many Monte Carlo Samples are Needed for Probabilistic Cost-Effectiveness Analyses?
Reza Yaesoubi
Value in Health | VOL. -
Reza YaesoubiReza Yaesoubi
01 Jul 2024
View more papers